| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |